Empery Asset Management, LP 13D and 13G filings for Hepion Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-01-19 10:48 am Sale |
2021-12-31 | 13G | Hepion Pharmaceuticals, Inc. HEPA |
Empery Asset Management, LP | 336 0.440% |
-3,664 (-91.61%) |
Filing |
| 2021-02-18 10:49 am Purchase |
2021-02-16 | 13G | Hepion Pharmaceuticals, Inc. HEPA |
Empery Asset Management, LP | 4,000 5.250% |
3,664 (+1091.38%) |
Filing |
| 2021-01-20 11:10 am Sale |
2020-12-31 | 13G | Hepion Pharmaceuticals, Inc. HEPA |
Empery Asset Management, LP | 336 1.050% |
-1,664 (-83.21%) |
Filing |
| 2020-12-02 11:12 am Purchase |
2020-11-25 | 13G | Hepion Pharmaceuticals, Inc. HEPA |
Empery Asset Management, LP | 2,000 6.910% |
2,000 (New Position) |
Filing |